Hitchhiking cancer vaccine makes progress in the clinic
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Bendta Schroeder | Koch Institute •
mit
Feb. 15, 2024 • ~11 min
Feb. 15, 2024 • ~11 min
/
32